Pfizer asked the U.S. government on Oct. 7 to allow use of its COVID-19 vaccine in children ages 5 to 11 – and if regulators agree, shots could begin within a matter of weeks.
Pfizer asked the U.S. government on Oct. 7 to allow use of its COVID-19 vaccine in children ages 5 to 11 – and if regulators agree, shots could begin within a matter of weeks.